QBW251 (Icenticaftor), which functions as a potentiator of the CFTR protein by binding and unlocking the CFTR channel to facilitate chloride ion transport92, has also shown clinical efficacy in treating cystic fibrosis and chronic obstructive pulmonary disease92–94. Here, CFTR is linked to cystic fibrosis.